期刊文献+

154例经皮冠状动脉介入术围手术期药物应用情况分析

下载PDF
导出
摘要 目的调查武警广东省总队医院经皮冠状动脉介入术(PCI)患者围手术药物应用情况,探讨药物使用的合理性,为PCI手术患者药物临床合理应用提供依据。方法调查154例行PCI手术的患者,记录患者一般情况,围手术期所用的抗血栓药物、抑酸药以及他汀类药物使用情况,并作出合理性分析。结果 154例患者平均年龄(60.91±11.92)岁,27.9%的患者术前使用了负荷剂量,术中100%选用普通肝素抗凝,32.5%急诊PCI患者加用替罗非班协助抗凝。术后96.1%的患者使用标准双抗疗法,79.9%使用低分子肝素,98.7%使用他汀类药物、47.4%使用抑酸药物。结论该院PCI围手术期用药大体合理,对缺血风险高的患者抗凝治疗有所加强,对患者消化道出血等事件有一定的重视,但对患者个体化、差异化治疗仍然有较大改进空间。
作者 李平
出处 《解放军药学学报》 CAS 2014年第2期181-183,共3页 Pharmaceutical Journal of Chinese People's Liberation Army
  • 相关文献

参考文献11

二级参考文献80

  • 1宋现涛,吕树铮,陈韵岱,苑飞,林运,田锐,陈欣,金泽宁,周渊,葛长江,孟康,柳弘.经皮冠状动脉介入治疗后患者住院期间合并上消化道出血分析[J].中华心血管病杂志,2007,35(4):308-311. 被引量:36
  • 2Vrints CJ. Pathophysiology of the no-reflow phenomenon [ J ]. Acute Card Care,2009,11 (2) :69-76. 被引量:1
  • 3Kuljk J, Flu W, Schouten O, et al. Timing of Noneardiae Surgery After Coronary Arterry Stenting With Bare Metal or Drug-Eluting Stents [ J ]. Am J Cardiol,2009,10,4 ( 9 ) : 1229 -1234. 被引量:1
  • 4Davignon J. Beneficial cardiovascular pleiotropic effects of statins [ J]. Circulation ,2004,109 (23S1) : Ⅲ39-43. 被引量:1
  • 5Pasceri V, Patti G, Nusca A, et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention : resuits from the ARMYDA ( Atorvastatin for Reduction of Myocardial Damage during Angio plasty) study [ J ]. Circulation,2004,110 (6) : 674-678. 被引量:1
  • 6Briguoria C, Colombob A, AiroldiF, et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction[J]. Eur Heart J,2004,25(20) : 1822-1828. 被引量:1
  • 7Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatmeut improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention; results of the ARMYDA-ACS randomized trial [ J ] . J Am Coll Cardiol, 2007,49 ( 12 ) : 1272-1278. 被引量:1
  • 8Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention : Results of the ARMYDA-RECAPTURE( Atorvastatin for Reduction of Myocardial Damage During Angioplasty ) Randomized Trial[J]. J Am Coll Cardiol,2009,54(6) :558-565. 被引量:1
  • 9Briguori C, Visconti G, Focaccio A, et al. Novel Approaches for Preventing or Limiting Events (Naples) II Trial: Impact of a Single High Loading Dosc of Atorvastatin on Periprocedural Myocardial Infarction[J]. J Am Coll Cardiol,2009,54(23) :2157-2163. 被引量:1
  • 10Laufs U, La Fata V, Plutz. J, et al. Upregulation of endothelial nitric oxidc synthase by HMG CoA reductase inhibitors[J]. Circulation, 1998,97(12) :1129-1135. 被引量:1

共引文献584

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部